Hunter Lee Fuentes

Urologist, husband, father, outdoor enthusiast, foodie

[Joel Hillelsohn @JoelHillelsohn]

This essay from @lee_c_zhao is exceptional—especially coming from a surgeon who routinely takes on complex cases few others would touch. It reframes surgical complications as a wicked learning environment, and shows how treating them as pain rather than guilt fuels growth. I wish I had read this when I first became an attending.

https://t.co/FYSCTeGYtW

[Urologic Oncology @UrolOncol]

Urologist-level variation in the management of T1a renal cell carcinoma: A population-based cohort study https://t.co/fTSTmRBWXw

[Rashid K. Sayyid @RKSayyid]

TiP: LIBERTAS: Ph 3 trial of APA + intermittent vs continuous ADT in mHSPC pts with PSA <0.2 following 6 mo of APA + ADT (n=333)
🔷Co-primary endpoints:
-Non-inferior 18 months rPFS
-Hot flash severity & frequency at 18 mo

@urotoday #GU24

[Scott Eggener @uroegg]

If you take care of testicular cancer patients (or want to in the future), not going to find a more comprehensive review than this......

@DrDarrenFeldman @jgleesonirl

Testicular cancer in 2023: Current status and recent progress https://t.co/Q6TapdoxX4

[European Urology Oncology @EurUrolOncol]

Contemporary Role of Lymph Node Dissection in Genitourinary Cancers: Where Are We in 2023?

https://t.co/nvMW4Lh3cz

@AmandaMyersMD @Albert0Briganti @BradLeibovichMD @UroMoschini @MRoupret @DrShariat @SpiessPhilippe @AStenzl @tanejauro @TouijerKarim @UroDocAsh

#UroSoMe

[Urologic Oncology @UrolOncol]

Re: Multiparametric MRI is not sufficient for prostate cancer staging: A single institutional experience validated by a multi-institutional regional collaborative. Thenappan Chandrasekar, Andrew Denisenko, Vasil Mico and Colleagues. Urological Oncology: … https://t.co/QxUQz6oxQW

[Laura Bukavina @LauraBukavinaMD]

great paper evaluating cTDNA LONG TERM role post +/- NAC and cystectomy of 68 NAC and 102 NAC Naive patients by @LDyrskjot ... lets summarize @CCR_AACR @BladderCancerUS

[Ricardo Soares @soares_uro]

Surgery in high risk prostate cancer:
- better symptom control
- less need for ADT
- seems to provide better overall survival vs. EBRT + Brachytherapy in younger patients (no RCT)
@adamkibel_uro @BWHUrology

[Hunter Lee Fuentes @HunterFuentes]

@dockovac To be fair they state a doctor gets 42 RVUs for a prostatectomy and that just isn’t true. That would be the total RVU for the hospital including lymph node dissection. The doctor is credited for only half of that. I agree with the sentiment just not the comparison of numbers.

[Urology Times @UrologyTimes]

"In the setting of BCG shortages, our patients need alternatives that do not deprive them of the chance of cure," said Dr. Ashish M. Kamat on the use of gemcitabine/docetaxel in IR-NMIBC. #urology #urologist #bladdercancer

Read more: https://t.co/MY0czKkRe7

[Simone Crivellaro @SimoneCrivella2]

Retrospective comparison #SPRASP vs #thulep for #BPH. Same surgeon. Similar outcomes. #SPsimple less early post op SUI. #Randomized trial on the way. Is #SP👎 the invasiveness of robotic to the level of endo? I'm still debating with my self @drjkaouk https://t.co/rmKp6BBa2L

[Bladder Cancer Advocacy Network @BladderCancerUS]

Attention clinicians! BCAN offers patient-friendly information on our web site about radical cystectomies, including an easy-to-follow video explaining what the surgery is. Click here to read our materials and please share with your patients! https://t.co/Fx86Y2LACr

[Urology Times @UrologyTimes]

Plant-based diets linked to lower risk of prostate cancer progression and recurrence. #GU23 #urology #urologist #pcsm

Read more: https://t.co/cQgkkB1Ofz

[Urologic Oncology @UrolOncol]

Deferred cytoreductive nephrectomy in the management of metastatic renal cell carcinoma: A systematic review and meta-analysis https://t.co/1UyLpdyZdN

[Hunter Lee Fuentes @HunterFuentes]

@RoboDocX @md_eun @bcm_urology @StLukesHealthTX Where do I find the description of the spiral technique?

[Michael Hofman @DrMHofman]

Lutetium-177 PSMA Theranostics: Optimal Sequencing in 2023 and Future Outlook https://t.co/qsS5ptNjeD
#ASCODailyNews @ASCO
Rapidly changing landscape: what do you think is next?

[Bodo Knudsen @BodoKnudsen]

Ouch... Changes for 2023.

[JJ Zhang, MD @DrJJZhang]

For surgeons who love both robotic and open surgery 😉
Check out our article + video of a combined approach to left-sided RNx + IVC thrombectomy @drjkaouk @mohameddmagdyy @ZSchwen @EthanFergusonMD @urogoldjournal

https://t.co/zHnDjBqAIZ

[Alastair Lamb @LambAlastair]

Useful talk from @BlackmurJames on malignant urinary obstr (MUO) @BAUSurology #BAUSOncology22

Neph tube better than stent if improved renal funct is goal

Stent better if chemotx planned as 1in4 risk of 30d sepsis w neph

MUO_Calculator looks v useful (do tweet link James)